Literature DB >> 18698338

Constituents of the Leaves and Stem Bark of Aglaia foveolata.

Angela A Salim1, Hee-Byung Chai, Ismail Rachman, Soedarsono Riswan, Leonardus B S Kardono, Norman R Farnsworth, Esperanza J Carcache-Blanco, A Douglas Kinghorn.   

Abstract

The previously known potent cytotoxic agent silvestrol (1) (0.002% w/w yield) and five new flavagline derivatives (2-6) were isolated from the leaves of Aglaia foveolata collected in Indonesia. The new compound 5 has an unprecedented cyclic amide moiety in its cyclopenta[b]benzopyran skeleton, while compound 6 is a novel benzo[b]oxepine derivative in which the oxepine ring is cleaved. Pyramidatine (7), a biogenetic precursor of the new flavaglines 2-6, was isolated from the leaf extract investigated. Silvestrol was also isolated from the stem bark of A. foveolata (yield of 0.02% w/w) along with a new baccharane-type triterpenoid (8). The structures of the new compounds were elucidated on the basis of their NMR and mass spectrometric data. All new compounds isolated were tested against a panel of cancer cell lines, but only compound 2 was cytotoxic (IC(50) range = 1.4-1.8 muM), and is the first member of the cyclopenta[b]benzopyran class found to exhibit this type of activity. Compound 2 also showed significant NF-kappaB inhibitory activity in an Elisa assay (IC(50) = 0.37 muM).

Entities:  

Year:  2007        PMID: 18698338      PMCID: PMC2034361          DOI: 10.1016/j.tet.2007.05.074

Source DB:  PubMed          Journal:  Tetrahedron        ISSN: 0040-4020            Impact factor:   2.457


  13 in total

1.  Phytochemical investigation of Aglaia andamanica.

Authors:  J Puripattanavong; S Weber; V Brecht; A W Frahm
Journal:  Planta Med       Date:  2000-12       Impact factor: 3.352

2.  Structure activity relationships of antiproliferative rocaglamide derivatives from Aglaia species (Meliaceae).

Authors:  F I Bohnenstengel; K G Steube; C Meyer; B W Nugroho; P D Hung; L C Kiet; P Proksch
Journal:  Z Naturforsch C J Biosci       Date:  1999 Jan-Feb

3.  Foveolins A and B, dammarane triterpenes from Aglaia foveolata.

Authors:  D Roux; M -T. Martin; M -T. Adeline; T Sevenet; A H. A. Hadi; M Païs
Journal:  Phytochemistry       Date:  1998-11-20       Impact factor: 4.072

4.  1H-cyclopenta[b]benzofuran lignans from Aglaia species inhibit cell proliferation and alter cell cycle distribution in human monocytic leukemia cell lines.

Authors:  F I Bohnenstengel; K G Steube; C Meyer; H Quentmeier; B W Nugroho; P Proksch
Journal:  Z Naturforsch C J Biosci       Date:  1999-12

5.  Cytotoxic flavaglines and bisamides from Aglaia edulis.

Authors:  Soyoung Kim; Young-Won Chin; Bao-Ning Su; Soedarsono Riswan; Leonardus B S Kardono; Johar J Afriastini; Heebyung Chai; Norman R Farnsworth; Geoffrey A Cordell; Steven M Swanson; A Douglas Kinghorn
Journal:  J Nat Prod       Date:  2006-12       Impact factor: 4.050

6.  Silvestrol regulates G2/M checkpoint genes independent of p53 activity.

Authors:  Qiuwen Mi; Soyoung Kim; Bang Yeon Hwang; Bao-Ning Su; Heebyung Chai; Zarema H Arbieva; A Douglas Kinghorn; Steven M Swanson
Journal:  Anticancer Res       Date:  2006 Sep-Oct       Impact factor: 2.480

Review 7.  Potential of cyclopenta[b]benzofurans from Aglaia species in cancer chemotherapy.

Authors:  Soyoung Kim; Angela A Salim; Steven M Swanson; A Douglas Kinghorn
Journal:  Anticancer Agents Med Chem       Date:  2006-07       Impact factor: 2.505

8.  Rocaglamide derivatives are potent inhibitors of NF-kappa B activation in T-cells.

Authors:  Bernd Baumann; Frank Bohnenstengel; Daniela Siegmund; Harald Wajant; Christoph Weber; Ingrid Herr; Klaus-Michael Debatin; Peter Proksch; Thomas Wirth
Journal:  J Biol Chem       Date:  2002-09-16       Impact factor: 5.157

9.  Bisamides from Aglaia species: structure analysis and potential to reverse drug resistance with cultured cells.

Authors:  E Saifah; J Puripattanavong; K Likhitwitayawuid; G A Cordell; H Chai; J M Pezzuto
Journal:  J Nat Prod       Date:  1993-04       Impact factor: 4.050

10.  Silvestrol and episilvestrol, potential anticancer rocaglate derivatives from Aglaia silvestris.

Authors:  Bang Yeon Hwang; Bao-Ning Su; Heebyung Chai; Qiuwen Mi; Leonardus B S Kardono; Johar J Afriastini; Soedarsono Riswan; Bernard D Santarsiero; Andrew D Mesecar; Robert Wild; Craig R Fairchild; Gregory D Vite; William C Rose; Norman R Farnsworth; Geoffrey A Cordell; John M Pezzuto; Steven M Swanson; A Douglas Kinghorn
Journal:  J Org Chem       Date:  2004-05-14       Impact factor: 4.354

View more
  13 in total

Review 1.  Potential of plant-derived natural products in the treatment of leukemia and lymphoma.

Authors:  David M Lucas; Patrick C Still; Lynette Bueno Pérez; Michael R Grever; A Douglas Kinghorn
Journal:  Curr Drug Targets       Date:  2010-07       Impact factor: 3.465

Review 2.  Chemistry and biology of rocaglamides (= flavaglines) and related derivatives from aglaia species (meliaceae).

Authors:  Sherif S Ebada; Neil Lajkiewicz; John A Porco; Min Li-Weber; Peter Proksch
Journal:  Prog Chem Org Nat Prod       Date:  2011

Review 3.  The relevance of higher plants in lead compound discovery programs.

Authors:  A Douglas Kinghorn; Li Pan; Joshua N Fletcher; Heebyung Chai
Journal:  J Nat Prod       Date:  2011-06-08       Impact factor: 4.050

Review 4.  Rocaglamide, silvestrol and structurally related bioactive compounds from Aglaia species.

Authors:  Li Pan; John L Woodard; David M Lucas; James R Fuchs; A Douglas Kinghorn
Journal:  Nat Prod Rep       Date:  2014-05-02       Impact factor: 13.423

5.  Total Syntheses of the Isomeric Aglain Natural Products Foveoglin A and Perviridisin B: Selective Excited-State Intramolecular Proton-Transfer Photocycloaddition.

Authors:  Wenyu Wang; Anthony Clay; Retheesh Krishnan; Neil J Lajkiewicz; Lauren E Brown; Jayaraman Sivaguru; John A Porco
Journal:  Angew Chem Int Ed Engl       Date:  2017-10-13       Impact factor: 15.336

6.  Isolation and characterization of minor analogues of silvestrol and other constituents from a large-scale re-collection of Aglaia foveolata.

Authors:  Li Pan; Leonardus B S Kardono; Soedarsono Riswan; Heebyung Chai; Esperanza J Carcache de Blanco; Caroline M Pannell; Djaja Doel Soejarto; Thomas G McCloud; David J Newman; A Douglas Kinghorn
Journal:  J Nat Prod       Date:  2010-10-12       Impact factor: 4.050

7.  Cyclopenta[b]benzofuran and Secodammarane Derivatives from the Stems of Aglaia stellatopilosa.

Authors:  Nuraqilah Othman; Li Pan; Michele Mejin; Julian C L Voong; Hee-byung Chai; Caroline M Pannell; A Douglas Kinghorn; Tiong C Yeo
Journal:  J Nat Prod       Date:  2016-03-14       Impact factor: 4.050

8.  Discovery of anticancer agents of diverse natural origin.

Authors:  A Douglas Kinghorn; Esperanza J Carcache de Blanco; Hee-Byung Chai; Jimmy Orjala; Norman R Farnsworth; D Doel Soejarto; Nicholas H Oberlies; Mansukh C Wani; David J Kroll; Cedric J Pearce; Steven M Swanson; Robert A Kramer; William C Rose; Craig R Fairchild; Gregory D Vite; Stuart Emanuel; David Jarjoura; Frederick O Cope
Journal:  Pure Appl Chem       Date:  2009-01-01       Impact factor: 2.453

9.  Bioactive flavaglines and other constituents isolated from Aglaia perviridis.

Authors:  Li Pan; Ulyana Muñoz Acuña; Jie Li; Nivedita Jena; Tran Ngoc Ninh; Caroline M Pannell; Heebyung Chai; James R Fuchs; Esperanza J Carcache de Blanco; Djaja D Soejarto; A Douglas Kinghorn
Journal:  J Nat Prod       Date:  2013-01-09       Impact factor: 4.050

Review 10.  Discovery of natural product anticancer agents from biodiverse organisms.

Authors:  A Douglas Kinghorn; Young-Won Chin; Steven M Swanson
Journal:  Curr Opin Drug Discov Devel       Date:  2009-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.